ArticleBrain and behavior2025

Venous Bicarbonate as a Prognostic Biomarker and Proposed Proxy for Vital Capacity to Be Used as an Eligibility Criterion in Amyotrophic Lateral Sclerosis Clinical Trials.

Juliette Foucher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.